Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc386_5, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 5 input genes in category / 24 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0004999 vasoactive intestinal polypeptide receptor activity 1.723E-7 4.135E-6 1.561E-5 4.135E-6 2 3
2 GO:0005184 neuropeptide hormone activity 3.023E-5 3.627E-4 1.370E-3 7.254E-4 2 33
3 GO:0031858 pituitary adenylate cyclase-activating polypeptide receptor binding 2.679E-4 1.608E-3 6.070E-3 6.431E-3 1 1
4 GO:0016521 pituitary adenylate cyclase activating polypeptide activity 2.679E-4 1.608E-3 6.070E-3 6.431E-3 1 1
5 GO:0005179 hormone activity 4.323E-4 2.075E-3 7.835E-3 1.038E-2 2 124
6 GO:0051428 peptide hormone receptor binding 4.547E-3 1.604E-2
6.058E-2
1.091E-1
 1 17
7 GO:0004970 ionotropic glutamate receptor activity 5.081E-3 1.604E-2
6.058E-2
1.219E-1
 1 19
8 GO:0005234 extracellularly glutamate-gated ion channel activity 5.348E-3 1.604E-2
6.058E-2
1.283E-1
 1 20
9 GO:0008066 glutamate receptor activity 7.214E-3 1.632E-2
6.163E-2
1.731E-1
 1 27
10 GO:0022824 transmitter-gated ion channel activity 7.481E-3 1.632E-2
6.163E-2
1.795E-1
 1 28
11 GO:0022835 transmitter-gated channel activity 7.481E-3 1.632E-2
6.163E-2
1.795E-1
 1 28
12 GO:0071855 neuropeptide receptor binding 8.279E-3 1.656E-2
6.253E-2
1.987E-1
 1 31
13 GO:0005231 excitatory extracellular ligand-gated ion channel activity 1.492E-2 2.754E-2
1.040E-1
3.580E-1
 1 56
14 GO:0030594 neurotransmitter receptor activity 1.835E-2 3.146E-2
1.188E-1
4.405E-1
 1 69
15 GO:0005230 extracellular ligand-gated ion channel activity 2.020E-2 3.232E-2
1.220E-1
4.848E-1
 1 76
Show 10 more annotations

2: GO: Biological Process [Display Chart] 5 input genes in category / 241 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0045762 positive regulation of adenylate cyclase activity 1.705E-7 2.809E-5 1.704E-4 4.110E-5 3 49
2 GO:0031281 positive regulation of cyclase activity 3.497E-7 2.809E-5 1.704E-4 8.428E-5 3 62
3 GO:0051349 positive regulation of lyase activity 3.497E-7 2.809E-5 1.704E-4 8.428E-5 3 62
4 GO:0045761 regulation of adenylate cyclase activity 5.989E-7 3.608E-5 2.188E-4 1.443E-4 3 74
5 GO:0031279 regulation of cyclase activity 1.013E-6 4.354E-5 2.640E-4 2.440E-4 3 88
6 GO:0051339 regulation of lyase activity 1.084E-6 4.354E-5 2.640E-4 2.612E-4 3 90
7 GO:0010578 regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway 1.614E-6 5.323E-5 3.228E-4 3.889E-4 2 8
8 GO:1900373 positive regulation of purine nucleotide biosynthetic process 1.988E-6 5.323E-5 3.228E-4 4.791E-4 3 110
9 GO:0030810 positive regulation of nucleotide biosynthetic process 1.988E-6 5.323E-5 3.228E-4 4.791E-4 3 110
10 GO:0006171 cAMP biosynthetic process 3.067E-6 7.391E-5 4.482E-4 7.391E-4 3 127
11 GO:0045981 positive regulation of nucleotide metabolic process 4.202E-6 8.439E-5 5.117E-4 1.013E-3 3 141
12 GO:1900544 positive regulation of purine nucleotide metabolic process 4.202E-6 8.439E-5 5.117E-4 1.013E-3 3 141
13 GO:1900371 regulation of purine nucleotide biosynthetic process 5.062E-6 8.745E-5 5.303E-4 1.220E-3 3 150
14 GO:0030808 regulation of nucleotide biosynthetic process 5.164E-6 8.745E-5 5.303E-4 1.245E-3 3 151
15 GO:0052652 cyclic purine nucleotide metabolic process 5.695E-6 8.745E-5 5.303E-4 1.373E-3 3 156
16 GO:0009190 cyclic nucleotide biosynthetic process 5.806E-6 8.745E-5 5.303E-4 1.399E-3 3 157
17 GO:0046058 cAMP metabolic process 6.262E-6 8.877E-5 5.383E-4 1.509E-3 3 161
18 GO:0007187 G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger 9.352E-6 1.252E-4 7.593E-4 2.254E-3 3 184
19 GO:0009187 cyclic nucleotide metabolic process 1.312E-5 1.665E-4 1.009E-3 3.163E-3 3 206
20 GO:1900542 regulation of purine nucleotide metabolic process 1.755E-5 2.115E-4 1.283E-3 4.230E-3 3 227
21 GO:0006140 regulation of nucleotide metabolic process 1.947E-5 2.235E-4 1.355E-3 4.693E-3 3 235
22 GO:0009152 purine ribonucleotide biosynthetic process 2.486E-5 2.724E-4 1.652E-3 5.992E-3 3 255
23 GO:0006164 purine nucleotide biosynthetic process 2.665E-5 2.793E-4 1.694E-3 6.424E-3 3 261
24 GO:0009260 ribonucleotide biosynthetic process 2.885E-5 2.826E-4 1.714E-3 6.953E-3 3 268
25 GO:0046390 ribose phosphate biosynthetic process 3.016E-5 2.826E-4 1.714E-3 7.267E-3 3 272
26 GO:0072522 purine-containing compound biosynthetic process 3.049E-5 2.826E-4 1.714E-3 7.348E-3 3 273
27 GO:0043267 negative regulation of potassium ion transport 3.419E-5 3.052E-4 1.851E-3 8.240E-3 2 35
28 GO:0007190 activation of adenylate cyclase activity 4.480E-5 3.856E-4 2.338E-3 1.080E-2 2 40
29 GO:0048662 negative regulation of smooth muscle cell proliferation 4.709E-5 3.914E-4 2.373E-3 1.135E-2 2 41
30 GO:0009165 nucleotide biosynthetic process 4.945E-5 3.953E-4 2.397E-3 1.192E-2 3 321
31 GO:1901293 nucleoside phosphate biosynthetic process 5.084E-5 3.953E-4 2.397E-3 1.225E-2 3 324
32 GO:0007189 adenylate cyclase-activating G protein-coupled receptor signaling pathway 1.853E-4 1.395E-3 8.461E-3 4.465E-2 2 81
33 GO:0042311 vasodilation 2.041E-4 1.490E-3 9.037E-3 4.918E-2 2 85
34 GO:0043266 regulation of potassium ion transport 2.339E-4 1.658E-3 1.005E-2
5.637E-2
 2 91
35 GO:0002878 negative regulation of acute inflammatory response to non-antigenic stimulus 2.685E-4 1.849E-3 1.121E-2
6.470E-2
 1 1
36 GO:1903524 positive regulation of blood circulation 3.670E-4 2.457E-3 1.490E-2
8.845E-2
 2 114
37 GO:0048660 regulation of smooth muscle cell proliferation 4.697E-4 3.059E-3 1.855E-2
1.132E-1
 2 129
38 GO:0048659 smooth muscle cell proliferation 4.991E-4 3.166E-3 1.920E-2
1.203E-1
 2 133
39 GO:0019233 sensory perception of pain 5.142E-4 3.178E-3 1.927E-2
1.239E-1
 2 135
40 GO:0043271 negative regulation of ion transport 5.929E-4 3.572E-3 2.166E-2
1.429E-1
 2 145
41 GO:0007188 adenylate cyclase-modulating G protein-coupled receptor signaling pathway 6.945E-4 4.083E-3 2.476E-2
1.674E-1
 2 157
42 GO:0002877 regulation of acute inflammatory response to non-antigenic stimulus 8.053E-4 4.621E-3 2.802E-2
1.941E-1
 1 3
43 GO:0050880 regulation of blood vessel size 8.618E-4 4.774E-3 2.895E-2
2.077E-1
 2 175
44 GO:0035150 regulation of tube size 8.716E-4 4.774E-3 2.895E-2
2.101E-1
 2 176
45 GO:0033002 muscle cell proliferation 9.832E-4 5.265E-3 3.193E-2
2.369E-1
 2 187
46 GO:0002525 acute inflammatory response to non-antigenic stimulus 1.074E-3 5.505E-3 3.338E-2
2.587E-1
 1 4
47 GO:0090274 positive regulation of somatostatin secretion 1.074E-3 5.505E-3 3.338E-2
2.587E-1
 1 4
48 GO:0003018 vascular process in circulatory system 1.146E-3 5.753E-3 3.489E-2
2.761E-1
 2 202
49 GO:0071651 positive regulation of chemokine (C-C motif) ligand 5 production 1.342E-3 6.600E-3 4.002E-2
3.234E-1
 1 5
50 GO:0006813 potassium ion transport 1.382E-3 6.659E-3 4.038E-2
3.330E-1
 2 222
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 5 input genes in category / 9 annotations before applied cutoff / 19061 genes in category

No results to display

4: Human Phenotype [Display Chart] 1 input genes in category / 8 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 5 input genes in category / 241 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0020467 abnormal circadian behavior 4.068E-6 9.803E-4 5.945E-3 9.803E-4 3 78
2 MP:0020472 arrhythmic circadian behavior persistence 1.229E-5 1.166E-3 7.073E-3 2.961E-3 2 12
3 MP:0020471 abnormal circadian behavior persistence 1.452E-5 1.166E-3 7.073E-3 3.499E-3 2 13
4 MP:0020473 abnormal circadian behavior phase 6.516E-5 3.382E-3 2.051E-2 1.570E-2 2 27
5 MP:0020470 shortened circadian behavior period 7.016E-5 3.382E-3 2.051E-2 1.691E-2 2 28
6 MP:0020468 abnormal circadian behavior period 1.234E-4 4.956E-3 3.006E-2 2.974E-2 2 37
7 MP:0003363 decreased circulating gonadotropin level 3.487E-4 1.200E-2
7.280E-2
8.403E-2
 2 62
8 MP:0001154 seminiferous tubule degeneration 8.353E-4 2.516E-2
1.526E-1
2.013E-1
 2 96
9 MP:0005118 decreased circulating pituitary hormone level 9.609E-4 2.573E-2
1.560E-1
2.316E-1
 2 103
10 MP:0003361 abnormal circulating gonadotropin level 1.155E-3 2.784E-2
1.688E-1
2.784E-1
 2 113
11 MP:0003972 decreased pituitary hormone level 1.389E-3 2.835E-2
1.719E-1
3.348E-1
 2 124
12 MP:0000189 hypoglycemia 1.412E-3 2.835E-2
1.719E-1
3.402E-1
 2 125
13 MP:0009326 absent maternal crouching 1.930E-3 3.579E-2
2.170E-1
4.652E-1
 1 4
14 MP:0004490 type IV spiral ligament fibrocyte degeneration 2.412E-3 4.153E-2
2.518E-1
5.814E-1
 1 5
15 MP:0030762 decreased adrenaline level 2.894E-3 4.520E-2
2.741E-1
6.975E-1
 1 6
16 MP:0005116 abnormal circulating pituitary hormone level 3.196E-3 4.520E-2
2.741E-1
7.702E-1
 2 189
17 MP:0002891 increased insulin sensitivity 3.196E-3 4.520E-2
2.741E-1
7.702E-1
 2 189
18 MP:0004296 abnormal type IV spiral ligament fibrocytes 3.376E-3 4.520E-2
2.741E-1
8.136E-1
 1 7
Show 13 more annotations

6: Domain [Display Chart] 5 input genes in category / 29 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 IPR001571 GPCR 2 VIP rcpt InterPro 5.698E-8 1.653E-6 6.547E-6 1.653E-6 2 2
2 IPR000532 Glucagon GIP secretin VIP InterPro 8.544E-7 4.955E-6 1.963E-5 2.478E-5 2 6
3 PS00260 GLUCAGON PROSITE 8.544E-7 4.955E-6 1.963E-5 2.478E-5 2 6
4 SM00070 GLUCA SMART 8.544E-7 4.955E-6 1.963E-5 2.478E-5 2 6
5 PF00123 Hormone 2 Pfam 8.544E-7 4.955E-6 1.963E-5 2.478E-5 2 6
6 SM00008 HormR SMART 1.705E-5 8.242E-5 3.265E-4 4.945E-4 2 25
7 PF02793 HRM Pfam 2.148E-5 8.899E-5 3.525E-4 6.229E-4 2 28
8 IPR017983 GPCR 2 secretin-like CS InterPro 3.186E-5 1.155E-4 4.575E-4 9.239E-4 2 34
9 PS50227 G PROTEIN RECEP F2 3 PROSITE 4.427E-5 1.167E-4 4.623E-4 1.284E-3 2 40
10 PS00649 G PROTEIN RECEP F2 1 PROSITE 4.427E-5 1.167E-4 4.623E-4 1.284E-3 2 40
11 IPR001879 GPCR 2 extracellular dom InterPro 4.427E-5 1.167E-4 4.623E-4 1.284E-3 2 40
12 PF00002 7tm 2 Pfam 6.945E-5 1.549E-4 6.137E-4 2.014E-3 2 50
13 PS00650 G PROTEIN RECEP F2 2 PROSITE 6.945E-5 1.549E-4 6.137E-4 2.014E-3 2 50
14 IPR017981 GPCR 2-like InterPro 1.002E-4 1.878E-4 7.441E-4 2.907E-3 2 60
15 IPR000832 GPCR 2 secretin-like InterPro 1.002E-4 1.878E-4 7.441E-4 2.907E-3 2 60
16 PS50261 G PROTEIN RECEP F2 4 PROSITE 1.036E-4 1.878E-4 7.441E-4 3.005E-3 2 61
17 IPR015523 VIP InterPro 2.669E-4 4.300E-4 1.703E-3 7.740E-3 1 1
18 IPR002284 GPCR 2 VIP rcpt 2 InterPro 2.669E-4 4.300E-4 1.703E-3 7.740E-3 1 1
19 IPR001771 GPCR 2 VIP rcpt 1 InterPro 8.005E-4 1.222E-3 4.840E-3 2.321E-2 1 3
20 IPR001508 Iono rcpt met InterPro 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
21 IPR019594 Glu/Gly-bd InterPro 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
22 PF10613 Lig chan-Glu bd Pfam 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
23 SM00918 Lig chan-Glu bd SMART 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
24 PF00060 Lig chan Pfam 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
25 SM00079 PBPe SMART 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
26 IPR001320 Iontro rcpt InterPro 4.795E-3 5.348E-3 2.119E-2
1.391E-1
 1 18
27 IPR001828 ANF lig-bd rcpt InterPro 9.837E-3 1.019E-2 4.036E-2
2.853E-1
 1 37
28 PF01094 ANF receptor Pfam 9.837E-3 1.019E-2 4.036E-2
2.853E-1
 1 37
29 IPR028082 Peripla BP I InterPro 1.037E-2 1.037E-2 4.107E-2
3.006E-1
 1 39
Show 24 more annotations

7: Pathway [Display Chart] 5 input genes in category / 14 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1269575 G alpha (s) signalling events BioSystems: REACTOME 8.994E-8 1.259E-6 4.094E-6 1.259E-6 4 146
2 M17941 Neuropeptides VIP and PACAP inhibit the apoptosis of activated T cells MSigDB C2 BIOCARTA (v6.0) 4.511E-5 3.158E-4 1.027E-3 6.316E-4 2 27
3 83053 Neuroactive ligand-receptor interaction BioSystems: KEGG 1.065E-4 4.972E-4 1.617E-3 1.492E-3 3 278
4 1269463 NGF-independant TRKA activation BioSystems: REACTOME 2.007E-3 6.742E-3 2.192E-2 2.809E-2 1 5
5 1269461 Activation of TRKA receptors BioSystems: REACTOME 2.408E-3 6.742E-3 2.192E-2 3.371E-2 1 6
6 1269572 Glucagon-type ligand receptors BioSystems: REACTOME 1.199E-2 2.798E-2
9.098E-2
1.679E-1
 1 30
Show 1 more annotation

8: Pubmed [Display Chart] 5 input genes in category / 832 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 17115416 PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. Pubmed 2.820E-16 2.346E-13 1.713E-12 2.346E-13 4 5
2 22700375 Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium. Pubmed 8.460E-16 3.519E-13 2.570E-12 7.039E-13 4 6
3 21295288 VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Pubmed 1.077E-12 1.494E-10 1.091E-9 8.961E-10 3 3
4 8146174 Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Pubmed 1.077E-12 1.494E-10 1.091E-9 8.961E-10 3 3
5 20691743 Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Pubmed 1.077E-12 1.494E-10 1.091E-9 8.961E-10 3 3
6 22059987 Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome. Pubmed 1.077E-12 1.494E-10 1.091E-9 8.961E-10 3 3
7 20150284 Vasoactive intestinal peptide-null mice demonstrate enhanced sweet taste preference, dysglycemia, and reduced taste bud leptin receptor expression. Pubmed 4.308E-12 3.983E-10 2.908E-9 3.584E-9 3 4
8 18616823 Select cognitive deficits in vasoactive intestinal peptide deficient mice. Pubmed 4.308E-12 3.983E-10 2.908E-9 3.584E-9 3 4
9 29155851 PAC1- and VPAC2 receptors in light regulated behavior and physiology: Studies in single and double mutant mice. Pubmed 4.308E-12 3.983E-10 2.908E-9 3.584E-9 3 4
10 20449688 PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium. Pubmed 1.077E-11 8.146E-10 5.948E-9 8.960E-9 3 5
11 12417650 Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. Pubmed 1.077E-11 8.146E-10 5.948E-9 8.960E-9 3 5
12 19470168 NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. Pubmed 8.784E-10 5.621E-8 4.105E-7 7.308E-7 3 18
13 20180986 CLOCK is suggested to associate with comorbid alcohol use and depressive disorders. Pubmed 8.784E-10 5.621E-8 4.105E-7 7.308E-7 3 18
14 20554694 Circadian clock gene polymorphisms in alcohol use disorders and alcohol consumption. Pubmed 1.043E-9 5.785E-8 4.224E-7 8.678E-7 3 19
15 20072116 Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Pubmed 1.043E-9 5.785E-8 4.224E-7 8.678E-7 3 19
16 21737879 VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling. Pubmed 2.178E-9 1.133E-7 8.270E-7 1.812E-6 3 24
17 23517078 VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
18 17885205 The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
19 15247290 Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
20 27381006 VIP impairs acquisition of the macrophage proinflammatory polarization profile. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
21 12429744 PAC1 receptor activation by PACAP-38 mediates Ca2+ release from a cAMP-dependent pool in human fetal adrenal gland chromaffin cells. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
22 18000164 PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
23 807467 [Quaternary structure of rabbit skeletal muscle glycogen synthetase]. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
24 16697281 Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
25 21157320 VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
26 24041830 Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
27 21769421 Gene expression of vasoactive intestinal peptide receptors in human lung cancer. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
28 12525573 Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
29 15750589 Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
30 9454823 Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
31 8389448 A vasoactive intestinal peptide antagonist inhibits non-small cell lung cancer growth. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
32 10801840 Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist. Alanine scanning and molecular modeling of the peptide. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
33 11027527 Tryptophan 67 in the human VPAC(1) receptor: crucial role for VIP binding. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
34 8784257 Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
35 17883247 Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
36 16934434 Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
37 23220033 Ameliorative effect of PACAP and VIP against increased permeability in a model of outer blood retinal barrier dysfunction. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
38 19712974 Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
39 19650041 The neurotransmitter VIP expands the pool of symmetrically dividing postnatal dentate gyrus precursors via VPAC2 receptors or directs them toward a neuronal fate via VPAC1 receptors. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
40 18032467 Metabolic rhythm abnormalities in mice lacking VIP-VPAC2 signaling. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
41 20180841 The role of the neuropeptides PACAP and VIP in the photic regulation of gene expression in the suprachiasmatic nucleus. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
42 18491042 Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
43 22531916 Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
44 18351280 Role of vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in the vaginal wall of women with stress urinary incontinence and pelvic organ prolapse. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
45 15009127 VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
46 18663606 The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
47 18383383 Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
48 17478887 Decreased VIP and VPAC2 receptor expression in the biological clock of the R6/2 Huntington's disease mouse. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
49 12225791 Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
50 11160313 Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. Pubmed 1.371E-8 1.630E-7 1.190E-6 1.141E-5 2 2
Show 45 more annotations

9: Interaction [Display Chart] 5 input genes in category / 170 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:VIP VIP interactions 3.091E-9 5.254E-7 3.003E-6 5.254E-7 3 13
2 int:ADCYAP1 ADCYAP1 interactions 6.456E-8 5.487E-6 3.136E-5 1.097E-5 3 34
3 int:VIPR1 VIPR1 interactions 1.238E-7 7.013E-6 4.009E-5 2.104E-5 3 42
4 int:VIPR2 VIPR2 interactions 1.582E-6 6.724E-5 3.843E-4 2.690E-4 3 97
5 int:AGPAT4 AGPAT4 interactions 3.507E-6 1.192E-4 6.815E-4 5.961E-4 2 11
6 int:SC5D SC5D interactions 4.972E-6 1.409E-4 8.052E-4 8.452E-4 2 13
7 int:DYM DYM interactions 1.471E-5 3.572E-4 2.042E-3 2.501E-3 2 22
8 int:SYNGR2 SYNGR2 interactions 1.757E-5 3.734E-4 2.134E-3 2.987E-3 2 24
9 int:HACD2 HACD2 interactions 2.583E-5 4.879E-4 2.789E-3 4.391E-3 2 29
10 int:PXDN PXDN interactions 2.958E-5 5.029E-4 2.874E-3 5.029E-3 2 31
11 int:GPR89A GPR89A interactions 4.234E-5 6.543E-4 3.740E-3 7.197E-3 2 37
12 int:EBP EBP interactions 6.009E-5 8.513E-4 4.866E-3 1.022E-2 2 44
13 int:GLMN GLMN interactions 1.999E-4 2.614E-3 1.494E-2 3.398E-2 2 80
14 int:YIPF3 YIPF3 interactions 3.250E-4 3.947E-3 2.256E-2
5.526E-2
 2 102
15 int:MME MME interactions 3.848E-4 4.362E-3 2.493E-2
6.542E-2
 2 111
16 int:C15orf61 C15orf61 interactions 8.471E-4 9.001E-3
5.145E-2
1.440E-1
 1 3
17 int:ADCYAP1R1 ADCYAP1R1 interactions 1.129E-3 1.129E-2
6.455E-2
1.920E-1
 1 4
18 int:SLC35F1 SLC35F1 interactions 1.412E-3 1.152E-2
6.583E-2
2.400E-1
 1 5
19 int:CPAMD8 CPAMD8 interactions 1.412E-3 1.152E-2
6.583E-2
2.400E-1
 1 5
20 int:SCT SCT interactions 1.412E-3 1.152E-2
6.583E-2
2.400E-1
 1 5
21 int:ATP5F1B ATP5F1B interactions 1.460E-3 1.152E-2
6.583E-2
2.481E-1
 2 217
22 int:TMEM41A TMEM41A interactions 1.694E-3 1.152E-2
6.583E-2
2.879E-1
 1 6
23 int:RAMP2 RAMP2 interactions 1.694E-3 1.152E-2
6.583E-2
2.879E-1
 1 6
24 int:AIG1 AIG1 interactions 1.694E-3 1.152E-2
6.583E-2
2.879E-1
 1 6
25 int:SPG11 SPG11 interactions 1.694E-3 1.152E-2
6.583E-2
2.879E-1
 1 6
26 int:TIMM10B TIMM10B interactions 1.976E-3 1.292E-2
7.384E-2
3.359E-1
 1 7
27 int:PCSK1N PCSK1N interactions 2.540E-3 1.489E-2
8.510E-2
4.317E-1
 1 9
28 int:GRID1 GRID1 interactions 2.540E-3 1.489E-2
8.510E-2
4.317E-1
 1 9
29 int:PRICKLE1 PRICKLE1 interactions 2.540E-3 1.489E-2
8.510E-2
4.317E-1
 1 9
30 int:RAMP1 RAMP1 interactions 2.822E-3 1.499E-2
8.568E-2
4.797E-1
 1 10
31 int:ELOVL2 ELOVL2 interactions 2.822E-3 1.499E-2
8.568E-2
4.797E-1
 1 10
32 int:SCTR SCTR interactions 2.822E-3 1.499E-2
8.568E-2
4.797E-1
 1 10
33 int:CERS5 CERS5 interactions 3.103E-3 1.552E-2
8.869E-2
5.276E-1
 1 11
34 int:RAMP3 RAMP3 interactions 3.103E-3 1.552E-2
8.869E-2
5.276E-1
 1 11
35 int:CMTM4 CMTM4 interactions 3.667E-3 1.663E-2
9.504E-2
6.233E-1
 1 13
36 int:TMEM245 TMEM245 interactions 3.948E-3 1.663E-2
9.504E-2
6.712E-1
 1 14
37 int:SLC35F2 SLC35F2 interactions 4.230E-3 1.663E-2
9.504E-2
7.191E-1
 1 15
38 int:EML1 EML1 interactions 4.230E-3 1.663E-2
9.504E-2
7.191E-1
 1 15
39 int:CDS1 CDS1 interactions 4.230E-3 1.663E-2
9.504E-2
7.191E-1
 1 15
40 int:LMBRD2 LMBRD2 interactions 4.230E-3 1.663E-2
9.504E-2
7.191E-1
 1 15
41 int:TMEM97 TMEM97 interactions 4.230E-3 1.663E-2
9.504E-2
7.191E-1
 1 15
42 int:SLC5A3 SLC5A3 interactions 4.511E-3 1.663E-2
9.504E-2
7.669E-1
 1 16
43 int:TMEM246 TMEM246 interactions 4.511E-3 1.663E-2
9.504E-2
7.669E-1
 1 16
44 int:VPS8 VPS8 interactions 4.511E-3 1.663E-2
9.504E-2
7.669E-1
 1 16
45 int:FASTKD1 FASTKD1 interactions 4.793E-3 1.663E-2
9.504E-2
8.148E-1
 1 17
46 int:SHH SHH interactions 4.793E-3 1.663E-2
9.504E-2
8.148E-1
 1 17
47 int:PIGN PIGN interactions 4.793E-3 1.663E-2
9.504E-2
8.148E-1
 1 17
48 int:TMEM164 TMEM164 interactions 4.793E-3 1.663E-2
9.504E-2
8.148E-1
 1 17
49 int:PM20D2 PM20D2 interactions 4.793E-3 1.663E-2
9.504E-2
8.148E-1
 1 17
50 int:MT-ATP8 MT-ATP8 interactions 5.355E-3 1.787E-2
1.021E-1
9.104E-1
 1 19
Show 45 more annotations

10: Cytoband [Display Chart] 5 input genes in category / 5 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 18p11 18p11 8.653E-4 3.123E-3 7.132E-3 4.326E-3 1 6
2 6q25 6q25 1.730E-3 3.123E-3 7.132E-3 8.650E-3 1 12
3 3p22 3p22 1.874E-3 3.123E-3 7.132E-3 9.370E-3 1 13
4 10q22 10q22 2.738E-3 3.422E-3 7.815E-3 1.369E-2 1 19
5 7q36.3 7q36.3 4.464E-3 4.464E-3 1.019E-2 2.232E-2 1 31

11: Transcription Factor Binding Site [Display Chart] 3 input genes in category / 51 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 5 input genes in category / 3 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 264 Vasoactive intestinal peptide receptor family genenames.org 1.812E-7 5.437E-7 9.969E-7 5.437E-7 2 3
2 1202 Glutamate ionotropic receptor delta type subunits genenames.org 5.496E-4 8.244E-4 1.511E-3 1.649E-3 1 2
3 542 Endogenous ligands genenames.org 1.647E-3 1.647E-3 3.019E-3 4.940E-3 2 237

13: Coexpression [Display Chart] 5 input genes in category / 339 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 15888489-Table1 Mouse Brain Chung05 134genes GeneSigDB 1.946E-4 4.129E-2
2.645E-1
6.595E-2
 2 103
2 15208663-SuppTable1b Human Colon Kim04 235genes GeneSigDB 4.067E-4 4.129E-2
2.645E-1
1.379E-1
 2 149
3 M2395 Genes up-regulated in pancreatic islets upon knockout of HNF1A [GeneID=6927]. MSigDB C2: CGP Curated Gene Sets (v6.0) 4.865E-4 4.129E-2
2.645E-1
1.649E-1
 2 163
4 M4181 Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 1 h. MSigDB C7: Immunologic Signatures (v6.0) 7.092E-4 4.129E-2
2.645E-1
2.404E-1
 2 197
5 M3601 Genes up-regulated in comparison of CD8 T cells at 0 h versus those at 48 h after stimulation with antigen-B7-1. MSigDB C7: Immunologic Signatures (v6.0) 7.236E-4 4.129E-2
2.645E-1
2.453E-1
 2 199
6 M8390 Genes up-regulated in spleen dendritic cells: CD8- versus CD8+. MSigDB C7: Immunologic Signatures (v6.0) 7.309E-4 4.129E-2
2.645E-1
2.478E-1
 2 200
7 M1205 Genes up-regulated in Kelly cells (neuroblastoma) by overexpressing INHBA [GeneID=3624] off a plasmid vector. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.512E-3 4.737E-2
3.034E-1
5.125E-1
 1 7
8 20460173-ImmPortCytokineReceptors Human Immune Kong10 308genes ImmPort CytokineReceptors GeneSigDB 1.665E-3 4.737E-2
3.034E-1
5.646E-1
 2 303
9 17148579-TableS2 Human Leukemia Bomben07 11genes GeneSigDB 2.375E-3 4.737E-2
3.034E-1
8.052E-1
 1 11
10 20161705-Table4 Mouse EmbryonicStemCell Layden10 15genes GeneSigDB 2.806E-3 4.737E-2
3.034E-1
9.514E-1
 1 13
11 12067990-Table3 Human Ovarian Bayani02 26genes GeneSigDB 3.238E-3 4.737E-2
3.034E-1
1.000E0
 1 15
12 M409 Top 20 genes expressed higher in epithelioid than in sarcomatoid mesothelioma samples. MSigDB C2: CGP Curated Gene Sets (v6.0) 3.669E-3 4.737E-2
3.034E-1
1.000E0
 1 17
13 17823238-TableS5 Human EmbryonicStemCell Soh07 469genes GeneSigDB 3.823E-3 4.737E-2
3.034E-1
1.000E0
 2 462
14 16540645-Table3 Human Lung LopezRio06 20genes GeneSigDB 3.884E-3 4.737E-2
3.034E-1
1.000E0
 1 18
15 M2100 Gene promoters preferentially bound by a mutated form of TP53 [GeneID=7157] in SKBR3 cells (breast cancer). MSigDB C2: CGP Curated Gene Sets (v6.0) 3.884E-3 4.737E-2
3.034E-1
1.000E0
 1 18
16 11779836-Table2 Human Ovarian Manderson02 24genes GeneSigDB 5.176E-3 4.737E-2
3.034E-1
1.000E0
 1 24
17 M7250 Up-regulated in human fetal pituitary tissue, compared to adult pituitary tissue MSigDB C2: CGP Curated Gene Sets (v6.0) 6.252E-3 4.737E-2
3.034E-1
1.000E0
 1 29
18 M4303 Common target genes down-regulated by all three Runx family members (RUNX1, RUNX2, and RUNX3 [GeneID=861;860;864]) in MEF cells (embryonic fibroblasts). MSigDB C2: CGP Curated Gene Sets (v6.0) 6.252E-3 4.737E-2
3.034E-1
1.000E0
 1 29
19 16178058-Table5 Human Brain Coco05 32genes GeneSigDB 6.682E-3 4.737E-2
3.034E-1
1.000E0
 1 31
20 M9066 Genes down-regulated in A172 cells (glioma, does not express MGMT [GeneID=4255]) by carmustine [PubChem=2578] at 48 h. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.897E-3 4.737E-2
3.034E-1
1.000E0
 1 32
21 15837765-Table2 Human Pancreas Akada05 44genes GeneSigDB 7.971E-3 4.737E-2
3.034E-1
1.000E0
 1 37
22 M1801 Up-regulated genes from the set D (Fig. 5a): specific signature shared by cells expressing MLL-AF4 [GeneID=4297;4299] alone and those expressing both MLL-AF4 and AF4-MLL fusion proteins. MSigDB C2: CGP Curated Gene Sets (v6.0) 8.186E-3 4.737E-2
3.034E-1
1.000E0
 1 38
23 11983058-Table2 Human Leukemia Bo02 50genes ColonTumor/NormalClassSeparation GeneSigDB 8.615E-3 4.737E-2
3.034E-1
1.000E0
 1 40
24 15980968-Table2b Human Brain Bandres05 50genes GeneSigDB 8.830E-3 4.737E-2
3.034E-1
1.000E0
 1 41
25 M2000 Genes with high-CpG-density promoters (HCP) bearing histone H3 K27 trimethylation mark (H327me3) in embryonic stem cells (ES). MSigDB C2: CGP Curated Gene Sets (v6.0) 8.830E-3 4.737E-2
3.034E-1
1.000E0
 1 41
26 18560354-Table1 Mouse StemCell Wotton08 50genes GeneSigDB 9.902E-3 4.737E-2
3.034E-1
1.000E0
 1 46
27 M2702 Genes down-regulated in primary epithelial breast cancer cell culture over-expressing activated CTNNB1 [Gene ID=1499] gene. MSigDB C6: Oncogenic Signatures (v6.0) 9.902E-3 4.737E-2
3.034E-1
1.000E0
 1 46
28 M5218 Genes bound by EWSR1-FLT1 [GeneID=2130;2321] fusion but whose expression did not change in STA-ET-7.2 cells (Ewing's sarcoma) after knockdown of EWSR1-FLT1 by RNAi. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.012E-2 4.737E-2
3.034E-1
1.000E0
 1 47
29 17970077-Table5 Human Viral Uchimura07 50genes GeneSigDB 1.012E-2 4.737E-2
3.034E-1
1.000E0
 1 47
30 M8645 Genes up-regulated in the nucleus accumbens (a major reward center in brain) 2 weeks after induction of deltaFosB, a FOSB [GeneID=2354] splice variant. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.033E-2 4.737E-2
3.034E-1
1.000E0
 1 48
31 20068086-ST1-4 Human Breast Lee10 52genes GeneSigDB 1.076E-2 4.737E-2
3.034E-1
1.000E0
 1 50
32 M6225 Genes up-regulated in Barrett's esophagus compared to the normal tissue. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.097E-2 4.737E-2
3.034E-1
1.000E0
 1 51
33 M16229 Primary up-regulated targets of TP53 [GeneID=7157] in the H1299 (lung cancer) cell line. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.247E-2 4.737E-2
3.034E-1
1.000E0
 1 58
34 17545589-Table2 Human Prostate Tamura07 70genes GeneSigDB 1.397E-2 4.737E-2
3.034E-1
1.000E0
 1 65
35 20096135-Table2 Human Liver Utispan10 75genes GeneSigDB 1.525E-2 4.737E-2
3.034E-1
1.000E0
 1 71
36 18849563-SuppTable5a Human Lung not cancer Bhattacharya09 84genes COPDvsControl GeneSigDB 1.525E-2 4.737E-2
3.034E-1
1.000E0
 1 71
37 17571080-SuppTable2c Human Leukemia Sun07 90genes GeneSigDB 1.546E-2 4.737E-2
3.034E-1
1.000E0
 1 72
38 18849563-SuppTable5c Human Lung not cancer Bhattacharya09 84genes FEV1PercentPredictedinCOPDAllSubjects GeneSigDB 1.546E-2 4.737E-2
3.034E-1
1.000E0
 1 72
39 18849563-SuppTable5b Human Lung not cancer Bhattacharya09 84genes FEV1PercentPredictedorFEV1/FVC GeneSigDB 1.546E-2 4.737E-2
3.034E-1
1.000E0
 1 72
40 18849563-SuppTable4 Human Lung not cancer Bhattacharya09 84genes GeneSigDB 1.546E-2 4.737E-2
3.034E-1
1.000E0
 1 72
41 16449976-SuppTable1 Human Esophagus Wang06 82genes GeneSigDB 1.568E-2 4.737E-2
3.034E-1
1.000E0
 1 73
42 15976005-Table3 Human Breast Graham05 82genes GeneSigDB 1.589E-2 4.737E-2
3.034E-1
1.000E0
 1 74
43 M1968 Genes with high-CpG-density promoters (HCP) without H3 methylation marks at either H3K4 or H3K27 in MCV8.1 cells (induced pluripotent cells, iPS). MSigDB C2: CGP Curated Gene Sets (v6.0) 1.717E-2 4.737E-2
3.034E-1
1.000E0
 1 80
44 M1451 Top 100 probe sets contrubuting to the negative side of the 2nd principal component; associated with adipocytic differentiation. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.717E-2 4.737E-2
3.034E-1
1.000E0
 1 80
45 M6222 Genes up-regulated in Jurkat cells (transformed T lymphocytes) after knockdown of BCL11B [GeneID=64919] by RNAi. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.738E-2 4.737E-2
3.034E-1
1.000E0
 1 81
46 11108479-SuppTable1 Human Colon Ben-Dor00 93genes GeneSigDB 1.738E-2 4.737E-2
3.034E-1
1.000E0
 1 81
47 M73 Genes up-regulated in primary tissue culture of epidermal kerationcytes after UVB irradiation. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.845E-2 4.737E-2
3.034E-1
1.000E0
 1 86
48 M6434 Top 100 genes positively associated with T-cell acute lymphoblastic leukemia MLL T-ALL) expressing MLL-ENL fusion [GeneID=4297;4298]. MSigDB C2: CGP Curated Gene Sets (v6.0) 1.866E-2 4.737E-2
3.034E-1
1.000E0
 1 87
49 17148579-TableS1 Human Leukemia Bomben07 122genes GeneSigDB 1.909E-2 4.737E-2
3.034E-1
1.000E0
 1 89
50 M17860 Genes down-regulated in primary tissue culture of epidermal kerationcytes after UVB irradiation. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.100E-2 4.737E-2
3.034E-1
1.000E0
 1 98
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 5 input genes in category / 398 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 BrainMap BrainAtlas - Mouse McCarroll FrontalCortex FrontalCortex Subtype Neuron.excitatory.Slc17a7.Parm1 FrontalCortex Top 200 Genes BrainMap BrainAtlas - Mouse McCarroll FrontalCortex FrontalCortex Subtype Neuron.excitatory.Slc17a7.Parm1 FrontalCortex Top 200 Genes BrainMap 3.228E-5 6.423E-3 4.217E-2 1.285E-2 3 326
2 BrainMap BrainAtlas - Mouse McCarroll FrontalCortex FrontalCortex Top 200 BrainMap BrainAtlas - Mouse McCarroll FrontalCortex FrontalCortex Top 200 BrainMap 3.228E-5 6.423E-3 4.217E-2 1.285E-2 3 326
3 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup3/Dlk1 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup3/Dlk1 BrainMap 4.207E-4 4.125E-2
2.708E-1
1.674E-1
 2 143
4 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Adenocarcinoma-NOS/2/3 Sample Type by Project: Shred 1/TCGA-Pancreas/Pancreatic Adenocarcinoma/Adenocarcinoma-NOS/2/3 TCGA-Pancreas 5.662E-4 4.125E-2
2.708E-1
2.254E-1
 2 166
5 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Cnn1/Mural.Rgs5.Acta2.Cnn1/FrontalCortex BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Mural/Mural/Acta2/Acta2,Rgs5//Cnn1/Mural.Rgs5.Acta2.Cnn1/FrontalCortex BrainMap 5.937E-4 4.125E-2
2.708E-1
2.363E-1
 2 170
6 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup1/Slc17a6 BrainMap/BrainAtlas - Mouse McCarroll/Lineage to Cells - regions (clevel sub)/Neuron/Neuron/inhibitory/subGroup1/Slc17a6 BrainMap 6.219E-4 4.125E-2
2.708E-1
2.475E-1
 2 174
7 appendix appendix Human Protein Atlas 7.485E-4 4.256E-2
2.794E-1
2.979E-1
 2 191
Show 2 more annotations

15: Computational [Display Chart] 4 input genes in category / 70 annotations before applied cutoff / 10037 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M18183 MODULE 121 Genes in the cancer module 121. MSigDb: C4 - CM: Cancer Modules (v6.0) 5.705E-4 3.993E-2
1.930E-1
 3.993E-2 2 99
2 M10197 MODULE 92 Secreted signaling molecules. MSigDb: C4 - CM: Cancer Modules (v6.0) 1.288E-3 4.508E-2
2.179E-1
9.016E-2
 2 149

16: MicroRNA [Display Chart] 5 input genes in category / 221 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-485-3p:TargetScan hsa-miR-485-3p TargetScan 1.939E-4 1.455E-2
8.698E-2
 4.285E-2 2 320
2 hsa-miR-539-3p:TargetScan hsa-miR-539-3p TargetScan 1.939E-4 1.455E-2
8.698E-2
 4.285E-2 2 320
3 hsa-miR-513b:PITA hsa-miR-513b:PITA TOP PITA 1.975E-4 1.455E-2
8.698E-2
 4.365E-2 2 323
4 hsa-miR-6749-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.832E-4 1.487E-2
8.891E-2
6.259E-2
 2 387
5 hsa-miR-485-3p:PITA hsa-miR-485-3p:PITA TOP PITA 3.365E-4 1.487E-2
8.891E-2
7.436E-2
 2 422
6 hsa-miR-1296:PITA hsa-miR-1296:PITA TOP PITA 2.766E-3 3.046E-2
1.821E-1
6.112E-1
 1 40
7 hsa-miR-133a-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.973E-3 3.046E-2
1.821E-1
6.570E-1
 1 43
8 hsa-miR-3126-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.111E-3 3.046E-2
1.821E-1
6.875E-1
 1 45
9 hsa-miR-1284:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.387E-3 3.046E-2
1.821E-1
7.485E-1
 1 49
10 hsa-miR-1298-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.456E-3 3.046E-2
1.821E-1
7.638E-1
 1 50
11 hsa-miR-6722-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.146E-3 3.046E-2
1.821E-1
9.163E-1
 1 60
12 CCACACA,MIR-147:MSigDB CCACACA,MIR-147:MSigDB MSigDB 4.215E-3 3.046E-2
1.821E-1
9.315E-1
 1 61
13 hsa-miR-4507:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.560E-3 3.046E-2
1.821E-1
1.000E0
 1 66
14 hsa-miR-4699-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.629E-3 3.046E-2
1.821E-1
1.000E0
 1 67
15 hsa-miR-6868-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.698E-3 3.046E-2
1.821E-1
1.000E0
 1 68
16 hsa-miR-3940-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.698E-3 3.046E-2
1.821E-1
1.000E0
 1 68
17 AATGGAG,MIR-136:MSigDB AATGGAG,MIR-136:MSigDB MSigDB 4.974E-3 3.046E-2
1.821E-1
1.000E0
 1 72
18 hsa-miR-875-5p:TargetScan hsa-miR-875-5p TargetScan 5.042E-3 3.046E-2
1.821E-1
1.000E0
 1 73
19 hsa-miR-6813-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.111E-3 3.046E-2
1.821E-1
1.000E0
 1 74
20 hsa-miR-885-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.318E-3 3.046E-2
1.821E-1
1.000E0
 1 77
21 hsa-miR-4283:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.387E-3 3.046E-2
1.821E-1
1.000E0
 1 78
22 hsa-miR-4448:Functional MTI Functional MTI miRTarbase 5.387E-3 3.046E-2
1.821E-1
1.000E0
 1 78
23 hsa-miR-6085:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.387E-3 3.046E-2
1.821E-1
1.000E0
 1 78
24 hsa-miR-4499:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.663E-3 3.046E-2
1.821E-1
1.000E0
 1 82
25 hsa-miR-6074:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.801E-3 3.046E-2
1.821E-1
1.000E0
 1 84
26 hsa-miR-6855-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.076E-3 3.046E-2
1.821E-1
1.000E0
 1 88
27 hsa-miR-4513:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.076E-3 3.046E-2
1.821E-1
1.000E0
 1 88
28 hsa-miR-1233:PITA hsa-miR-1233:PITA TOP PITA 6.283E-3 3.046E-2
1.821E-1
1.000E0
 1 91
29 hsa-miR-452-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.283E-3 3.046E-2
1.821E-1
1.000E0
 1 91
30 hsa-miR-4803:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.420E-3 3.046E-2
1.821E-1
1.000E0
 1 93
31 hsa-miR-596:PITA hsa-miR-596:PITA TOP PITA 6.489E-3 3.046E-2
1.821E-1
1.000E0
 1 94
32 hsa-miR-324-5p:PITA hsa-miR-324-5p:PITA TOP PITA 6.558E-3 3.046E-2
1.821E-1
1.000E0
 1 95
33 hsa-miR-4494:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.558E-3 3.046E-2
1.821E-1
1.000E0
 1 95
34 hsa-miR-934:PITA hsa-miR-934:PITA TOP PITA 6.696E-3 3.046E-2
1.821E-1
1.000E0
 1 97
35 hsa-miR-8066:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.765E-3 3.046E-2
1.821E-1
1.000E0
 1 98
36 hsa-miR-550:PITA hsa-miR-550:PITA TOP PITA 7.384E-3 3.046E-2
1.821E-1
1.000E0
 1 107
37 AAAGGAT,MIR-501:MSigDB AAAGGAT,MIR-501:MSigDB MSigDB 8.141E-3 3.046E-2
1.821E-1
1.000E0
 1 118
38 hsa-miR-548o-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.141E-3 3.046E-2
1.821E-1
1.000E0
 1 118
39 hsa-miR-1323:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.278E-3 3.046E-2
1.821E-1
1.000E0
 1 120
40 hsa-miR-138-5p:Non-Functional MTI Non-Functional MTI miRTarbase 8.622E-3 3.046E-2
1.821E-1
1.000E0
 1 125
41 hsa-miR-5196-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.622E-3 3.046E-2
1.821E-1
1.000E0
 1 125
42 hsa-miR-4709-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 8.691E-3 3.046E-2
1.821E-1
1.000E0
 1 126
43 hsa-miR-1262:PITA hsa-miR-1262:PITA TOP PITA 9.034E-3 3.046E-2
1.821E-1
1.000E0
 1 131
44 hsa-miR-496.2:TargetScan hsa-miR-496.2 TargetScan 9.103E-3 3.046E-2
1.821E-1
1.000E0
 1 132
45 hsa-miR-500a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.103E-3 3.046E-2
1.821E-1
1.000E0
 1 132
46 hsa-miR-4530:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.240E-3 3.046E-2
1.821E-1
1.000E0
 1 134
47 hsa-miR-1238-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.309E-3 3.046E-2
1.821E-1
1.000E0
 1 135
48 hsa-miR-597:PITA hsa-miR-597:PITA TOP PITA 9.309E-3 3.046E-2
1.821E-1
1.000E0
 1 135
49 TGTATGA,MIR-485-3P:MSigDB TGTATGA,MIR-485-3P:MSigDB MSigDB 9.309E-3 3.046E-2
1.821E-1
1.000E0
 1 135
50 hsa-miR-362-5p:PITA hsa-miR-362-5p:PITA TOP PITA 9.378E-3 3.046E-2
1.821E-1
1.000E0
 1 136
Show 45 more annotations

17: Drug [Display Chart] 5 input genes in category / 1948 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID003046357 Brn 1142179 Stitch 2.135E-12 2.569E-9 2.094E-8 4.160E-9 4 20
2 CID000060139 AC1Q5KVS Stitch 2.638E-12 2.569E-9 2.094E-8 5.138E-9 4 21
3 CID000162562 AC1L4RIC Stitch 5.035E-11 3.269E-8 2.665E-7 9.808E-8 3 5
4 CID000155558 nor TTX Stitch 2.819E-10 1.030E-7 8.394E-7 5.492E-7 3 8
5 CID000125200 p-azidophenylglyoxal Stitch 2.819E-10 1.030E-7 8.394E-7 5.492E-7 3 8
6 CID000004024 MDL-12330A Stitch 3.171E-10 1.030E-7 8.394E-7 6.178E-7 4 66
7 CID000209655 S-V3 Stitch 4.228E-10 1.177E-7 9.592E-7 8.237E-7 3 9
8 CID000174706 Xestospongine B Stitch 6.040E-10 1.471E-7 1.199E-6 1.177E-6 3 10
9 CID000003044 NSC95943 Stitch 1.175E-9 2.543E-7 2.073E-6 2.289E-6 4 91
10 CID006332158 AC1O3MDH Stitch 1.868E-9 3.638E-7 2.966E-6 3.638E-6 4 102
11 CID000184644 DAPTA Stitch 2.818E-9 4.990E-7 4.068E-6 5.489E-6 3 16
12 CID000209652 Sv 1 Stitch 3.421E-9 5.554E-7 4.527E-6 6.664E-6 3 17
13 CID000131307 4-DAMP mustard Stitch 4.105E-9 6.151E-7 5.015E-6 7.997E-6 3 18
14 CID000003604 hexamethonium Stitch 7.330E-9 1.020E-6 8.314E-6 1.428E-5 4 143
15 CID000114813 AC1Q5H8E Stitch 8.652E-9 1.124E-6 9.160E-6 1.685E-5 4 149
16 CID000168120 8-Br Stitch 1.041E-8 1.193E-6 9.727E-6 2.028E-5 4 156
17 CID000445754 nM-1 Stitch 1.041E-8 1.193E-6 9.727E-6 2.028E-5 4 156
18 CID009543496 2d41 Stitch 1.471E-8 1.508E-6 1.229E-5 2.865E-5 3 27
19 CID000007266 diaminopropane Stitch 1.471E-8 1.508E-6 1.229E-5 2.865E-5 3 27
20 CID010450565 R-2 Stitch 1.647E-8 1.604E-6 1.308E-5 3.208E-5 3 28
21 CID000001456 OD-q Stitch 1.813E-8 1.681E-6 1.371E-5 3.531E-5 4 179
22 CID006426631 Rp-cAMPS Stitch 2.506E-8 2.219E-6 1.809E-5 4.882E-5 4 194
23 CID010413188 Rp-8-CPT-cAMPS Stitch 3.289E-8 2.786E-6 2.271E-5 6.407E-5 3 35
24 CID000656969 phosphodiesterase 4 inhibitor Stitch 3.588E-8 2.872E-6 2.342E-5 6.989E-5 3 36
25 CID000150195 dichlororuthenium Stitch 3.834E-8 2.872E-6 2.342E-5 7.468E-5 2 2
26 CID000447705 AC1L9L52 Stitch 3.834E-8 2.872E-6 2.342E-5 7.468E-5 2 2
27 CID000122145 CHAPSO Stitch 4.238E-8 3.058E-6 2.493E-5 8.256E-5 3 38
28 CID000004367 L-NNA Stitch 6.301E-8 4.383E-6 3.573E-5 1.227E-4 4 244
29 CID000004548 NPC 15437 Stitch 7.623E-8 5.120E-6 4.174E-5 1.485E-4 3 46
30 CID000045469 sodium nitroprusside Stitch 8.257E-8 5.362E-6 4.371E-5 1.608E-4 4 261
31 CID000001912 8-bromo-cAMP Stitch 8.645E-8 5.432E-6 4.428E-5 1.684E-4 4 264
32 CID000123663 PEG-SS Stitch 1.045E-7 6.364E-6 5.188E-5 2.036E-4 3 51
33 CID000093313 dithiobis(succinimidyl propionate Stitch 1.468E-7 8.667E-6 7.065E-5 2.860E-4 3 57
34 CID000193072 Nk 2 Stitch 1.717E-7 9.836E-6 8.018E-5 3.344E-4 3 60
35 CID000005631 AC1L1KS5 Stitch 2.220E-7 1.236E-5 1.007E-4 4.324E-4 4 334
36 CID000001822 AC1L1CBF Stitch 2.301E-7 1.245E-5 1.015E-4 4.482E-4 4 337
37 CID000036511 Substance P Stitch 2.469E-7 1.300E-5 1.060E-4 4.810E-4 4 343
38 CID000003661 atropine sulfate Stitch 2.587E-7 1.326E-5 1.081E-4 5.039E-4 4 347
39 CID005289296 N6-methyl-(R)-roscovitine Stitch 2.865E-7 1.431E-5 1.167E-4 5.582E-4 3 71
40 CID000000187 acetylcholine Stitch 3.031E-7 1.476E-5 1.203E-4 5.904E-4 4 361
41 CID000003758 IBMX Stitch 3.273E-7 1.555E-5 1.268E-4 6.376E-4 4 368
42 CID000003541 AC1MBZ1C Stitch 4.004E-7 1.857E-5 1.514E-4 7.799E-4 4 387
43 CID000656725 reactive blue 2 Stitch 5.308E-7 2.405E-5 1.960E-4 1.034E-3 3 87
44 CID000093771 BSOCOES Stitch 5.749E-7 2.545E-5 2.075E-4 1.120E-3 2 6
45 CID000020382 tetradotoxin Stitch 5.990E-7 2.593E-5 2.114E-4 1.167E-3 4 428
46 CID000124335 Btzo-tdmap Stitch 1.379E-6 5.598E-5 4.563E-4 2.687E-3 2 9
47 CID000086805 salmefamol Stitch 1.379E-6 5.598E-5 4.563E-4 2.687E-3 2 9
48 CID000134497 iodophenylalanine Stitch 1.379E-6 5.598E-5 4.563E-4 2.687E-3 2 9
49 CID000001233 ibotenic acid Stitch 1.475E-6 5.864E-5 4.781E-4 2.874E-3 3 122
50 ctd:D020866 omega-Conotoxin GVIA CTD 1.724E-6 6.717E-5 5.475E-4 3.358E-3 2 10
Show 45 more annotations

18: Disease [Display Chart] 5 input genes in category / 129 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C0149931 Migraine Disorders DisGeNET Curated 2.438E-7 3.145E-5 1.711E-4 3.145E-5 4 243
2 C3536893 Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor DisGeNET BeFree 9.847E-7 6.351E-5 3.456E-4 1.270E-4 3 76
3 C0859976 Idiopathic achalasia of esophagus DisGeNET Curated 4.184E-6 1.799E-4 9.790E-4 5.398E-4 2 11
4 C1849193 PEELING SKIN SYNDROME DisGeNET Curated 1.034E-5 3.334E-4 1.814E-3 1.334E-3 2 17
5 C1832588 Chromosome 11p11.2 Deletion Syndrome DisGeNET Curated 1.444E-5 3.725E-4 2.027E-3 1.863E-3 2 20
6 C0262493 Polyp of gallbladder DisGeNET BeFree 3.085E-4 5.308E-3 2.888E-2 3.980E-2 1 1
7 C1881600 Malignant Vipoma DisGeNET BeFree 3.085E-4 5.308E-3 2.888E-2 3.980E-2 1 1
8 C0271183 Severe myopia DisGeNET Curated 3.292E-4 5.308E-3 2.888E-2 4.246E-2 2 94
9 C0038436 Post-Traumatic Stress Disorder DisGeNET BeFree 3.725E-4 5.339E-3 2.905E-2 4.805E-2 2 100
10 C0239182 Watery diarrhea DisGeNET BeFree 6.170E-4 7.960E-3 4.331E-2
7.960E-2
 1 2
11 C4053506 Rapid-Onset Obesity with Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation DisGeNET BeFree 9.254E-4 9.083E-3 4.942E-2
1.194E-1
 1 3
12 C0268784 Myeloma kidney DisGeNET BeFree 9.254E-4 9.083E-3 4.942E-2
1.194E-1
 1 3
13 C3887612 Psychomotor Agitation DisGeNET Curated 9.254E-4 9.083E-3 4.942E-2
1.194E-1
 1 3
14 C1654637 androgen independent prostate cancer DisGeNET BeFree 9.858E-4 9.083E-3 4.942E-2
1.272E-1
 2 163
15 C0026896 Myasthenia Gravis DisGeNET Curated 1.059E-3 9.109E-3 4.956E-2
1.366E-1
 2 169
16 C0011993 Vipoma DisGeNET Curated 1.542E-3 1.105E-2
6.013E-2
1.989E-1
 1 5
17 C0520788 Posttransfusion viral hepatitis DisGeNET BeFree 1.542E-3 1.105E-2
6.013E-2
1.989E-1
 1 5
18 C0878773 Overactive Bladder DisGeNET Curated 1.542E-3 1.105E-2
6.013E-2
1.989E-1
 1 5
19 C1542327 Fetus or newborn affected by alcohol transmitted via placenta or breast milk DisGeNET Curated 1.850E-3 1.137E-2
6.186E-2
2.387E-1
 1 6
20 C0086768 Pancreatic Cholera DisGeNET BeFree 1.850E-3 1.137E-2
6.186E-2
2.387E-1
 1 6
21 C1527336 Sjogren's Syndrome DisGeNET Curated 1.851E-3 1.137E-2
6.186E-2
2.387E-1
 2 224
22 C0026205 Miosis disorder DisGeNET Curated 2.774E-3 1.529E-2
8.320E-2
3.579E-1
 1 9
23 C3203102 Idiopathic pulmonary arterial hypertension DisGeNET Curated 2.834E-3 1.529E-2
8.320E-2
3.656E-1
 2 278
24 C0031511 Pheochromocytoma DisGeNET Curated 2.935E-3 1.529E-2
8.320E-2
3.786E-1
 2 283
25 C0005686 Urinary Bladder Diseases DisGeNET Curated 3.082E-3 1.529E-2
8.320E-2
3.976E-1
 1 10
26 C0543698 hypersensitive syndrome DisGeNET BeFree 3.082E-3 1.529E-2
8.320E-2
3.976E-1
 1 10
27 C0525045 Mood Disorders DisGeNET Curated 3.578E-3 1.710E-2
9.302E-2
4.616E-1
 2 313
28 C0004936 Mental disorders DisGeNET Curated 3.760E-3 1.732E-2
9.425E-2
4.851E-1
 2 321
29 C0020256 Congenital Hydrocephalus DisGeNET BeFree 4.313E-3 1.854E-2
1.009E-1
5.563E-1
 1 14
30 C2931404 Albright's hereditary osteodystrophy DisGeNET Curated 4.313E-3 1.854E-2
1.009E-1
5.563E-1
 1 14
31 C0936282 Blastoma DisGeNET BeFree 4.620E-3 1.923E-2
1.046E-1
5.960E-1
 1 15
32 20090807:Vasan Aortic root size GWAS 4.928E-3 1.926E-2
1.048E-1
6.357E-1
 1 16
33 C0424139 Anxiety and fear DisGeNET BeFree 4.928E-3 1.926E-2
1.048E-1
6.357E-1
 1 16
34 C0344315 Depressed mood DisGeNET Curated 5.235E-3 1.986E-2
1.081E-1
6.753E-1
 1 17
35 C0400914 Acute hepatitis C DisGeNET BeFree 5.542E-3 1.986E-2
1.081E-1
7.149E-1
 1 18
36 C0242488 Acute Lung Injury DisGeNET Curated 5.542E-3 1.986E-2
1.081E-1
7.149E-1
 1 18
37 C0700323 Observation of Neuromuscular Block DisGeNET BeFree 5.849E-3 2.036E-2
1.108E-1
7.546E-1
 1 19
38 C0011615 Dermatitis, Atopic DisGeNET Curated 6.099E-3 2.036E-2
1.108E-1
7.868E-1
 2 411
39 C0010403 Cryoglobulinemia DisGeNET BeFree 6.156E-3 2.036E-2
1.108E-1
7.942E-1
 1 20
40 C3494506 Pseudohypoparathyroidism, Type Ia DisGeNET Curated 6.770E-3 2.123E-2
1.155E-1
8.734E-1
 1 22
41 C0013595 Eczema DisGeNET Curated 6.905E-3 2.123E-2
1.155E-1
8.907E-1
 2 438
42 C0263338 Chronic urticaria DisGeNET BeFree 7.077E-3 2.123E-2
1.155E-1
9.130E-1
 1 23
43 C3495919 Enthesitis-Related Arthritis DisGeNET BeFree 7.077E-3 2.123E-2
1.155E-1
9.130E-1
 1 23
44 C0020452 Hyperemia DisGeNET Curated 7.691E-3 2.255E-2
1.227E-1
9.921E-1
 1 25
45 C0030193 Pain DisGeNET Curated 7.986E-3 2.289E-2
1.246E-1
1.000E0
 2 472
46 C0221232 Welts DisGeNET BeFree 9.530E-3 2.672E-2
1.454E-1
1.000E0
 1 31
47 C0034951 Refractive Errors DisGeNET Curated 9.836E-3 2.700E-2
1.469E-1
1.000E0
 1 32
48 C2751492 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED DisGeNET Curated 1.198E-2 3.219E-2
1.751E-1
1.000E0
 1 39
49 C0206718 Ganglioneuroblastoma DisGeNET Curated 1.289E-2 3.327E-2
1.810E-1
1.000E0
 1 42
50 C4054122 Rat Adrenal Gland Pheochromocytoma DisGeNET BeFree 1.289E-2 3.327E-2
1.810E-1
1.000E0
 1 42
Show 45 more annotations